Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial by Kim, Edward S, MD, Hirsh, Vera, MD, Mok, Tony, Prof, Socinski, Mark A, Prof, Gervais, Radj, MD, Wu, Yi-Long, Prof, Li, Long-Yun, Prof, Watkins, Claire L, MSc, Sellers, Mark V, MSc, Lowe, Elizabeth S, MD, Sun, Yan, MD, Liao, Mei-Lin, Prof, Østerlind, Kell, MD, Reck, Martin, MD, Armour, Alison A, FRCR, Shepherd, Frances A, Prof, Lippman, Scott M, Prof, Douillard, Jean-Yves, Prof

Get full text